amiodarone has been researched along with Nausea in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
Excerpt | Relevance | Reference |
---|---|---|
"Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 7.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
"Amiodarone and cedilanid may be the proper drugs for the treatment of paroxysmal atrial fibrillation in the elderly." | 3.73 | Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old. ( Cao, J; Chen, DY; Zhu, BP, 2006) |
"Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 3.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
"Dronedarone is a benzofuran derivative resembling amiodarone that was intended to reduce the iodine-associated tissue deposition and organ toxicity seen with the latter." | 1.43 | The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature. ( Brent Mitchell, L; Kuriachan, V; Rizkallah, J, 2016) |
" Drug or metabolite concentrations in plasma and RBCs correlated directly with daily dosage of amiodarone." | 1.27 | Plasma and red blood cell concentrations of amiodarone during chronic therapy. ( Heger, JJ; Prystowsky, EN; Solow, EB; Zipes, DP, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rizkallah, J | 1 |
Kuriachan, V | 1 |
Brent Mitchell, L | 1 |
Chen, DY | 1 |
Cao, J | 1 |
Zhu, BP | 1 |
Heger, JJ | 1 |
Solow, EB | 1 |
Prystowsky, EN | 1 |
Zipes, DP | 1 |
Morady, F | 1 |
Sauve, MJ | 1 |
Malone, P | 1 |
Shen, EN | 1 |
Schwartz, AB | 1 |
Bhandari, A | 1 |
Keung, E | 1 |
Sung, RJ | 1 |
Scheinman, MM | 1 |
4 other studies available for amiodarone and Nausea
Article | Year |
---|---|
The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Dronedarone; Fatal Outcome | 2016 |
Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardi | 2006 |
Plasma and red blood cell concentrations of amiodarone during chronic therapy.
Topics: Amiodarone; Anorexia; Benzofurans; Erectile Dysfunction; Erythrocytes; Humans; Male; Nausea; Saliva; | 1984 |
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Topics: Aged; Amiodarone; Anorexia; Ataxia; Benzofurans; Female; Heart Arrest; Humans; Lung Diseases; Male; | 1983 |